These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3365915)

  • 21. Relative bioavailability of imipramine (Tofranil) coated tablets in healthy volunteers.
    Ullmann U; Lehnfeld R; Bliesath H; Birkel M; Gebbing H; Gräve M; Wolf H
    Int J Clin Pharmacol Ther; 2001 Jun; 39(6):271-6. PubMed ID: 11430636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of verapamil, diltiazem, and labetalol on the bioavailability and metabolism of imipramine.
    Hermann DJ; Krol TF; Dukes GE; Hussey EK; Danis M; Han YH; Powell JR; Hak LJ
    J Clin Pharmacol; 1992 Feb; 32(2):176-83. PubMed ID: 1613128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonlinear kinetics of imipramine in low and medium plasma level ranges.
    Sindrup SH; Brøsen K; Gram LF
    Ther Drug Monit; 1990 Sep; 12(5):445-9. PubMed ID: 2293406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imipramine pharmacokinetics in depressed geriatric patients.
    Benetello P; Furlanut M; Zara G; Baraldo M
    Int J Clin Pharmacol Res; 1990; 10(3):191-5. PubMed ID: 2228344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pharmacokinetics of acamprosate.
    Saivin S; Hulot T; Chabac S; Potgieter A; Durbin P; Houin G
    Clin Pharmacokinet; 1998 Nov; 35(5):331-45. PubMed ID: 9839087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imipramine demethylation and hydroxylation: impact of the sparteine oxidation phenotype.
    Brøsen K; Otton SV; Gram LF
    Clin Pharmacol Ther; 1986 Nov; 40(5):543-9. PubMed ID: 3769385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of imipramine to platelet membranes is lower in alcoholics than in controls.
    Javors M; Blaisdell G; Lee J; Bowden C
    Alcohol Drug Res; 1987; 7(5-6):453-9. PubMed ID: 3620011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of effect of oral activated charcoal on imipramine clearance.
    Goldberg MJ; Park GD; Spector R; Fischer LJ; Feldman RD
    Clin Pharmacol Ther; 1985 Sep; 38(3):350-3. PubMed ID: 4028632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible influence of carbamazepine on plasma imipramine concentrations in children with attention deficit hyperactivity disorder.
    Brown CS; Wells BG; Cold JA; Froemming JH; Self TH; Jabbour JT
    J Clin Psychopharmacol; 1990 Oct; 10(5):359-62. PubMed ID: 2258453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma levels of imipramine and metabolites in 68 hospitalized children.
    Preskorn SH; Bupp SJ; Weller EB; Weller RA
    J Am Acad Child Adolesc Psychiatry; 1989 May; 28(3):373-5. PubMed ID: 2738003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of posture on imipramine and desipramine plasma concentrations.
    Abalan F; Schweiger K; Hecquet D; Brachet-Liermain A; Sousselier M; Rigal F
    J Clin Psychopharmacol; 1990 Aug; 10(4):301-2. PubMed ID: 2286705
    [No Abstract]   [Full Text] [Related]  

  • 32. Imipramine: a model substance in pharmacokinetic research.
    Gram LF
    Acta Psychiatr Scand Suppl; 1988; 345():81-4. PubMed ID: 3067542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Model for the kinetics of imipramine and its metabolites in adolescents.
    Dell RB; Hein K; Ramakrishnan R; Puig-Antich J; Cooper T
    Ther Drug Monit; 1990 Sep; 12(5):450-9. PubMed ID: 2293407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical usefulness of monitoring serum levels of imipramine and desipramine in patients treated for endogenous depression].
    Szymura-Oleksiak J; Wasieczko A
    Psychiatr Pol; 1991; 25(1):54-60. PubMed ID: 1780375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variability in metabolism of imipramine and desipramine using urinary excretion data.
    Ramey K; Ma JD; Best BM; Atayee RS; Morello CM
    J Anal Toxicol; 2014; 38(6):368-74. PubMed ID: 24782142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disposition of bupropion in healthy volunteers and subjects with alcoholic liver disease.
    DeVane CL; Laizure SC; Stewart JT; Kolts BE; Ryerson EG; Miller RL; Lai AA
    J Clin Psychopharmacol; 1990 Oct; 10(5):328-32. PubMed ID: 2124217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of fused-core and conventional particle size columns by LC-MS/MS and UV: application to pharmacokinetic study.
    Song W; Pabbisetty D; Groeber EA; Steenwyk RC; Fast DM
    J Pharm Biomed Anal; 2009 Oct; 50(3):491-500. PubMed ID: 19540084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated myo-inositol in gray matter of recently detoxified but not long-term abstinent alcoholics: a preliminary MR spectroscopy study.
    Schweinsburg BC; Taylor MJ; Videen JS; Alhassoon OM; Patterson TL; Grant I
    Alcohol Clin Exp Res; 2000 May; 24(5):699-705. PubMed ID: 10832912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma levels and antidepressive effect of imipramine.
    Gram LF; Reisby N; Ibsen I; Nagy A; Dencker SJ; Bech P; Petersen GO; Christiansen J
    Clin Pharmacol Ther; 1976 Mar; 19(3):318-24. PubMed ID: 770049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of imipramine N-demethylation by fluvoxamine in Chinese young men.
    Xu ZH; Huang SL; Zhou HH
    Zhongguo Yao Li Xue Bao; 1996 Sep; 17(5):399-402. PubMed ID: 9863158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.